Literature DB >> 8950456

Immunohistochemical identification of type II alternatively activated dendritic macrophages (RM 3/1+3, MS-1+/-, 25F9-) in psoriatic dermis.

N Djemadji-Oudjiel1, S Goerdt, V Kodelja, M Schmuth, C E Orfanos.   

Abstract

Immunological mechanisms play an important role in the pathogenesis of psoriasis. Lesional psoriatic skin-derived T-cell clones have been shown to stimulate keratinocyte proliferation and to predominantly express a T-helper type 1 cytokine pattern. However, T-helper type 2-like cytokines have also been identified in some psoriatic T-cell clones. In parallel to the T-helper type 1/type 2 dichotomy, a distinction between interferon-gamma-induced (classically activated) macrophages and interleukin-4/glucocorticoid-induced (alternatively activated) macrophages has been put forward as a conceptual framework for a better understanding of immunopathological processes. In the present study, the phenotype of mononuclear phagocytes in psoriatic skin lesions (n = 21), allergic contact dermatitis (n = 4) and normal skin (n = 2) was investigated using a panel of monoclonal antibodies (mAb) against monocytes/macrophages and dendritic cells (mAb MS-1, RM 3/1, and 25F9 against subsets of in vitro alternatively activated macrophages, and mAb against myeloid antigens CD1a, CD11b, CD11c, CD34, CD36, and CD68). With regard to mononuclear phagocytes, psoriatic skin was found to be compartmentalized into epidermis, subepidermal space, and upper and lower dermis. RM 3/1++ +, MS-1+/-, 25F9- dendritic macrophages previously classified as type II alternatively activated macrophages were the dominant dermal macrophage population in psoriatic skin, while intraepidermal and epithelium-lining macrophages expressed a different, presumably classically activated, macrophage phenotype (RM 3/1-, MS-1-, 25F9-, CD68+2, CD11b+2). In allergic contact dermatitis, a classical T-helper type 1 disease, RM 3/1++ + macrophages were less prominent. Since MS-1 high molecular weight protein is much more sensitive to interferon-gamma-induced suppression than RM 3/1 antigen, a predominance of T-helper type 1 cytokines in psoriasis could explain why dermal dendritic macrophages do not express the fully induced MS-1++ +, RM 3/1++ +, 25F9+/- phenotype of type I alternatively activated macrophages.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950456     DOI: 10.1007/bf02505293

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  64 in total

1.  Organization of the monocyte/macrophage system of normal human skin.

Authors:  K Weber-Matthiesen; W Sterry
Journal:  J Invest Dermatol       Date:  1990-07       Impact factor: 8.551

2.  Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q.

Authors:  J Tomfohrde; A Silverman; R Barnes; M A Fernandez-Vina; M Young; D Lory; L Morris; K D Wuepper; P Stastny; A Menter
Journal:  Science       Date:  1994-05-20       Impact factor: 47.728

3.  MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions.

Authors:  R Gillitzer; K Wolff; D Tong; C Müller; T Yoshimura; A A Hartmann; G Stingl; R Berger
Journal:  J Invest Dermatol       Date:  1993-08       Impact factor: 8.551

4.  Mast cells and macrophages in early relapsing psoriasis.

Authors:  C Schubert; E Christophers
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

5.  T cells involved in psoriasis vulgaris belong to the Th1 subset.

Authors:  J F Schlaak; M Buslau; W Jochum; E Hermann; M Girndt; H Gallati; K H Meyer zum Büschenfelde; B Fleischer
Journal:  J Invest Dermatol       Date:  1994-02       Impact factor: 8.551

6.  The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response.

Authors:  K Uyemura; M Yamamura; D F Fivenson; R L Modlin; B J Nickoloff
Journal:  J Invest Dermatol       Date:  1993-11       Impact factor: 8.551

7.  Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function.

Authors:  A N McKenzie; J A Culpepper; R de Waal Malefyt; F Brière; J Punnonen; G Aversa; A Sato; W Dang; B G Cocks; S Menon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Characterization of lesional psoriatic skin T lymphocyte clones.

Authors:  M Barna; F G Snijdewint; F L van der Heijden; J D Bos; M L Kapsenberg
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1994

9.  Dissection of macrophage differentiation pathways in cutaneous macrophage disorders and in vitro.

Authors:  V Kodelja; S Goerdt
Journal:  Exp Dermatol       Date:  1994-12       Impact factor: 3.960

10.  Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro.

Authors:  L J Montaner; A G Doyle; M Collin; G Herbein; P Illei; W James; A Minty; D Caput; P Ferrara; S Gordon
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  16 in total

1.  Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues.

Authors:  Oliver Politz; Alexei Gratchev; Peter A G McCourt; Kai Schledzewski; Pierre Guillot; Sophie Johansson; Gunbjorg Svineng; Peter Franke; Christoph Kannicht; Julia Kzhyshkowska; Paola Longati; Florian W Velten; Staffan Johansson; Sergij Goerdt
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

Review 2.  Immunopathogenesis of psoriasis.

Authors:  Brian J Nickoloff; Jian-Zhong Qin; Frank O Nestle
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

3.  Deepening our understanding of immune sentinels in the skin.

Authors:  Frank O Nestle; Brian J Nickoloff
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

4.  Macrophage activation switching: an asset for the resolution of inflammation.

Authors:  F Porcheray; S Viaud; A-C Rimaniol; C Léone; B Samah; N Dereuddre-Bosquet; D Dormont; G Gras
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

5.  Arginase in parasitic infections: macrophage activation, immunosuppression, and intracellular signals.

Authors:  Cinthia C Stempin; Laura R Dulgerian; Vanina V Garrido; Fabio M Cerban
Journal:  J Biomed Biotechnol       Date:  2009-12-09

6.  Immunohistological analysis of immune cells in blistering skin lesions.

Authors:  Mahmoud R Hussein; Fayed Mahammad Nagy Ali; Abd-Elhady M M Omar
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

7.  Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation.

Authors:  Honglin Wang; Thorsten Peters; Daniel Kess; Anca Sindrilaru; Tsvetelina Oreshkova; Nico Van Rooijen; Athanasios Stratis; Andreas C Renkl; Cord Sunderkötter; Meinhard Wlaschek; Ingo Haase; Karin Scharffetter-Kochanek
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

8.  Misbehaving macrophages in the pathogenesis of psoriasis.

Authors:  Rachael A Clark; Thomas S Kupper
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

9.  Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro.

Authors:  C Schebesch; V Kodelja; C Müller; N Hakij; S Bisson; C E Orfanos; S Goerdt
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

10.  METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages.

Authors:  Irina Ushach; Amanda M Burkhardt; Cynthia Martinez; Peter A Hevezi; Peter Arne Gerber; Bettina Alexandra Buhren; Holger Schrumpf; Ricardo Valle-Rios; Monica I Vazquez; Bernhard Homey; Albert Zlotnik
Journal:  Clin Immunol       Date:  2014-12-05       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.